Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma

Huda Salman, Alejandra Perez, Joseph A. Sparano, Howard Ratech, Abdissa Negassa, Una Hopkins, Gina Villani, Joachim Fuks, Peter H. Wiernik

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences